XML 17 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Jun. 27, 2020
Jun. 29, 2019
Cash flows from operating activities:    
Net income (loss) $ 77,289 $ (37,286)
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 60,677 58,634
Amortization of right-of-use lease assets 29,467 0
Stock-based compensation 73,605 71,608
Other non-cash items, net (2,786) (2,721)
Changes in operating assets and liabilities, excluding the effects of acquisitions:    
Accounts receivable 54,662 88,254
Accounts payable and accrued expenses 4,255 4,124
Accrued compensation and benefits 878 (23,442)
Deferred revenue 3,357 25,325
Accrued income taxes (44,445) (12,777)
Other current assets and prepaid expenses 15,311 (6,336)
Operating lease liabilities (8,871) 0
Other noncurrent assets and liabilities (63,565) 64,546
Net cash provided by operating activities 199,834 229,929
Cash flows from investing activities:    
Additions to property and equipment (15,412) (59,579)
Purchases of short- and long-term marketable securities (26,087) (18,950)
Proceeds from sales of short- and long-term marketable securities 1,521 0
Proceeds from maturities of short- and long-term marketable securities 24,271 20,677
Acquisitions of businesses, net of cash acquired (468,520) (86,737)
Purchases of investments 0 (7,500)
Purchase of intangible assets (11,050) 0
Settlement of net investment hedges (1,729) 4,509
Net cash used in investing activities (497,006) (147,580)
Cash flows from financing activities:    
Proceeds from issuance of Senior Notes 1,000,000 0
Borrowings under credit facility 455,000 205,000
Repayments of Senior Notes (500,000) 0
Repayments of borrowings under credit facility (490,125) (150,000)
Repurchases of common stock 0 (89,995)
Proceeds from issuance of common stock 8,980 4,158
Debt issuance costs (17,083) 0
Contingent consideration 0 (1,575)
Debt early redemption premium (15,000) 0
Payments of withholding taxes in connection with stock-based awards (33,232) (44,191)
Net cash provided by (used in) financing activities 408,540 (76,603)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (4,127) 2,143
Net change in cash, cash equivalents, and restricted cash 107,241 7,889
Cash, cash equivalents, and restricted cash, beginning of period 270,689 261,093
Cash, cash equivalents, and restricted cash, end of period $ 377,930 $ 268,982